Commentary on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)

John M. Kane, MD

Published: May 15, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Since the introduction of the secondgeneration or so-called "atypical" antipsychotics in the mid 1990s, they have become far more widely used in the United States than the first-generation or conventional antipsychotics. Given the increased costs associated with these newer medications, attempts to delineate their potential advantages and disadvantages from a clinical, public health, and health economic standpoint are certainly important.

When evaluating the effects of antipsychotic drugs in schizophrenia, it is important to recognize the heterogeneity of the illness in terms of symptom patterns, severity, course, and treatment response (both therapeutic and adverse).’ ‹

Volume: 67

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Prevalence and Correlates of Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder

Prevalence and correlates of obsessive-compulsive symptoms and OCD were identified from the case records of over 22,500...

Read More...